BGI, Australian Firm Sign MOU to Develop Dx Technology

Aug 24, 2018

|

NEW YORK (GenomeWeb) – BGI said on Thursday it has signed a memorandum of understanding with Australian firm Xing Technology aimed at the translation of diagnostic technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BGI, Australian Firm Sign MOU to Develop Dx Technology

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

4D Path Prepping FDA Submission for AI-Enabled Breast Cancer Digital Pathology Product

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence

Sponsorships